tretazicar has been researched along with Glioma in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chang, D; Chang, HF; Chen, BM; Chen, SH; Chen, TC; Collins, S; Kasahara, N; Lin, SC; Lu, YC; Sun, JM; Tai, CK; Wang, HE; Wang, W; Wu, SF | 1 |
1 other study(ies) available for tretazicar and Glioma
| Article | Year |
|---|---|
Efficient Prodrug Activator Gene Therapy by Retroviral Replicating Vectors Prolongs Survival in an Immune-Competent Intracerebral Glioma Model.
Topics: Animals; Aziridines; Brain Neoplasms; Cell Line, Tumor; Cytosine Deaminase; Escherichia coli Proteins; Flucytosine; Genetic Therapy; Genetic Vectors; Glioma; Leukemia Virus, Gibbon Ape; Neoplasms, Experimental; Nitroreductases; Prodrugs; Rats, Inbred F344; Saccharomyces cerevisiae Proteins | 2020 |